VipIR

About 908 Devices

908 Devices is revolutionizing chemical analysis by making it simple, smart, and speedy for critical, life-altering applications. Founded in 2012 and publicly traded on Nasdaq (MASS), the company leverages proprietary miniaturized mass spectrometry and FTIR technologies to deliver handheld devices that provide actionable intelligence in seconds. Its strategic focus is on high-impact markets including the illicit drug crisis, toxic chemical exposure, and global security threats, supported by a growing portfolio of products and strategic acquisitions.